Paclitaxel for Injection Albumin Bound: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Paclitaxel for Injection Albumin Bound

• A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer
  NCT06202261 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
  NCT06821503 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 16 locations
• Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer
  NCT06752811 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Pyrotinib Plus Trastuzumab and Chemotherapy for HER2-Positive Early Breast Cancer
  NCT07635342 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: Female · 1 location

Common questions

How many recruiting trials involve Paclitaxel for Injection Albumin Bound?

4 recruiting trials across 8 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.